[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGF\u00df1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 78, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 56, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 908461, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 650708, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith J.D.", "age": 56, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8622, "open": 0.8793, "dayLow": 0.8787, "dayHigh": 1.07, "regularMarketPreviousClose": 0.8622, "regularMarketOpen": 0.8793, "regularMarketDayLow": 0.8787, "regularMarketDayHigh": 1.07, "payoutRatio": 0.0, "beta": 0.213, "forwardPE": -0.8888889, "volume": 2022687, "regularMarketVolume": 2022687, "averageVolume": 6165943, "averageVolume10days": 10009300, "averageDailyVolume10Day": 10009300, "bid": 0.9881, "ask": 1.07, "bidSize": 4, "askSize": 4, "marketCap": 68516144, "fiftyTwoWeekLow": 0.323, "fiftyTwoWeekHigh": 2.79, "allTimeHigh": 17.88, "allTimeLow": 0.323, "fiftyDayAverage": 1.20572, "twoHundredDayAverage": 1.23433, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 48741152, "profitMargins": 0.0, "floatShares": 34636891, "sharesOutstanding": 65880914, "sharesShort": 1138820, "sharesShortPriorMonth": 1067607, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0173, "heldPercentInsiders": 0.00341, "heldPercentInstitutions": 0.63838, "shortRatio": 0.25, "shortPercentOfFloat": 0.0361, "impliedSharesOutstanding": 65880915, "bookValue": 0.024, "priceToBook": 43.333332, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -103986000, "trailingEps": -1.58, "forwardEps": -1.17, "enterpriseToEbitda": -0.493, "52WeekChange": -0.11864406, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 1.04, "targetHighPrice": 4.0, "targetLowPrice": 0.39, "targetMeanPrice": 2.46333, "targetMedianPrice": 3.0, "recommendationMean": 2.4, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 28131000, "totalCashPerShare": 0.427, "ebitda": -98950000, "totalDebt": 8356000, "quickRatio": 1.471, "currentRatio": 1.959, "debtToEquity": 524.874, "returnOnAssets": -0.80629, "returnOnEquity": -2.12511, "grossProfits": -2587000, "freeCashflow": -52716752, "operatingCashflow": -83326000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IOBT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "IO Biotech, Inc.", "shortName": "IO Biotech, Inc.", "corporateActions": [], "postMarketTime": 1761955160, "regularMarketTime": 1761940801, "exchange": "NMS", "messageBoardId": "finmb_1685354464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 20.6217, "regularMarketPrice": 1.04, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "postMarketChangePercent": -0.9326866, "postMarketPrice": 1.0303, "postMarketChange": -0.009699941, "regularMarketChange": 0.1778, "regularMarketDayRange": "0.8787 - 1.07", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 6165943, "fiftyTwoWeekLowChange": 0.71699995, "fiftyTwoWeekLowChangePercent": 2.219814, "fiftyTwoWeekRange": "0.323 - 2.79", "fiftyTwoWeekHighChange": -1.75, "fiftyTwoWeekHighChangePercent": -0.6272402, "fiftyTwoWeekChangePercent": -11.864406, "earningsTimestampStart": 1747224300, "earningsTimestampEnd": 1747224300, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.58, "epsForward": -1.17, "epsCurrentYear": -0.94, "priceEpsCurrentYear": -1.106383, "fiftyDayAverageChange": -0.16571999, "fiftyDayAverageChangePercent": -0.13744484, "twoHundredDayAverageChange": -0.1943301, "twoHundredDayAverageChangePercent": -0.15743771, "ipoExpectedDate": "2021-11-05", "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "displayName": "IO Biotech", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]